glp 1 drugs and gallstones Why are GLP-1 agonists being used to treat patients with nonalcoholic fatty liver disease? Preventive Screening for GLP-1RA-Induced Gallstone

Research digest: sglt2 inhibition in kidney and liver disease

You're tired of caffeine-based products that cause crashes

While the video does not provide medical advice, it gives visual learners a clearer sense of how KLOW fits into a busy lab environment and reinforces the research-only status of the product

J Neurosci Res 66:10031008 Dringen R, Pawlowski PG, Hirrlinger J (2005) Peroxide detoxification by brain cells

BPC-157 has demonstrated neuroprotective effects in multiple animal models (Sikiric et al., Current Neuropharmacology, 2017), including protection of enteric neurons

Moreover, the study failed to reach its clinical endpoint for both active Crohns disease (Scholmerich et al., 2017) and multiple sclerosis (Voldsgaard et al., 2015